Depatuxizumab Mafodotin (Depatux-M) Plus Temozolomide (Tmz) In Recurrent Glioblastoma Patients: Real-World Experience From A Multicenter Study Of Italian Association Of Neuro-Oncology (Aino).

Mario Caccese,Marta Padovan,Marica Eoli,Alessia Pellerino,Simona Rizzato,Claudia Caserta,Matteo Simonelli,Maria Michiara,Vittorina Zagonel,Roberta Ruda,Giuseppe Lombardi

JOURNAL OF CLINICAL ONCOLOGY（2020）

引用 15|浏览35

暂无评分

摘要

2544Background: Precision medicine is a promising tool in oncology. Depatux-M is a new antibody-drug conjugate, consisting of a specific antibody against activated EGFR and a cytotoxic agent with a...

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要